Rocket Doctor Partners with Melanoma Canada to Expand Access to Follow-Up Care for At-Risk Patients

‎‎ New collaboration will connect patients flagged during mobile skin cancer screenings with Rocket Doctor physicians across Ontario, Alberta, and British Columbia

●Rocket Doctor has partnered with Melanoma Canada to provide timely follow-up care for patients identified as at-risk during mobile skin cancer screenings.
 
‎●Patients without a family doctor will be directly referred to physicians on Rocket Doctor through a streamlined digital intake process.

●The Mole Mobile campaign travels across Alberta, British Columbia, Ontario, and Quebec, providing free screenings in both remote and urban communities.

●Skin cancer is the most common cancer in Canada, with 1 in 3 cancer diagnoses being skin-related — more than breast, prostate, lung, and colon cancers combined.

‎●22 Canadians are diagnosed with melanoma every day, and 3 Canadians die daily from this serious form of skin cancer.

‎●The partnership is expected to increase patient visits on Rocket Doctor’s platform, improving access to care and continuity for at-risk individuals.

Toronto, ON, May 20, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is proud to announce that its virtual care subsidiary, Rocket Doctor Inc., has partnered with Melanoma Canada to help bridge the care gap for individuals identified as at-risk for melanoma and other skin cancers during mobile screening events across the country.

Melanoma Canada’s Mole Mobile units, Canada’s first mobile skin cancer screening clinics, presented by Neutrogena, a Kenvue brand travel across Alberta, British Columbia, Ontario, and Quebec, offering free skin checks from certified dermatologists in both remote and urban communities. Through this partnership, Rocket Doctor will provide patients who do not have a family physician with timely access to follow-up appointments via its virtual care platform.

“Too many Canadians are going without the care they need simply because they don’t have a family doctor,” said Dr. William Cherniak, Founder and CEO of Rocket Doctor. “By partnering with Melanoma Canada, we’re making it easier for patients identified during these critical screenings to get connected to a physician quickly, ensuring no one falls through the cracks.”

Dermatologists working in the Mole Mobile units will complete an on-site risk assessment and referral form for patients who require follow-up. These forms can then be uploaded directly to Rocket Doctor’s intake system, enabling efficient, streamlined review and timely access to appropriate care.